systems.bio
Bebek Lab, Case Western Reserve University

Gürkan Bebek, PhD, MS
2109 Adelbert Rd
BRB 921
Cleveland, OH 44106
U.S.A.
Welcome to the home page for Dr. Gurkan Bebek and Bebek Lab, where we develop systems biology algorithms and methods to analyze and integrate large omic datasets. We study complex phenotypes to address problems about human health and diseases.
Our research highlights include significant projects such as cancer drug response networks, causal regulatory network analysis, and recent advances in understanding heterogeneity in Alzheimer’s disease. We have published over 50 peer-reviewed articles. Our work spans various domains, including proteomics, genomics, metagenomics, epigenetics, pharmacogenomics, and clinical informatics.
Meet our team of dedicated researchers. Each member brings unique expertise to our lab, contributing to our mission of advancing medical research. Stay updated with our latest news, achievements, and upcoming events. Feel free to connect with us through our social media links and contact information provided below.
news
May 17, 2025 |
Submit your paper to PSB 2026 Session on Systems Biology and Network Analysis
From Multi-omics Integration to Biological Mechanism. ![]() ![]() |
---|---|
May 17, 2025 |
Protein Co-Aggregates Differ in Rapid vs. Sporadic Alzheimer’s Disease Paper is accepted for publication in Alzheimer’s Research and Therapy. ![]() ![]() |
Dec 15, 2024 |
SYBB 402 is now offered as an online asynchronous class. Register soon! ![]() ![]() |
Mar 12, 2024 | Our paper, “CADRE: Utilizing CAncer Drug Response nEtwork for Drug Synergy Prediction,” is accepted for oral presentation at RECOMB-CCB 2024! 🎉 Looking forward to the event in Boston, MA, on April 27-28, 2024. |
Oct 22, 2023 | Our new website is live on systems.bio ! |
latest posts
selected publications
-
Human alveolar macrophages display marked hypo-responsiveness to IFN-γin both proteomic and gene expression analysisPlos one, 2024
-
CSF immune cell phenotypes and their related pathway activation differ by Alzheimers disease stage compared to normal controlsIn Alzheimer’s Association International Conference , 2024